Post by
fdfd12 on Aug 16, 2016 5:47pm
I think it is obvious
For CXR to move up and have a chance to reach $30, $40 and more,
CEO Mark Thompson must RESIGN.
This stock will not move up otherwise.
Too many short sellers are after him and think he is a joke.
He is capable of bringing a startup company to $800M - $1B
company but not past that figure.
He must hand it off to someone else to continue the rest.
Obviously, his big mistake was buying a company bigger than they were
and thinking the drugs will sell as much as they had in the past for AMCO.
What he didn't see happening is price competition, buying off patent drugs,
Hillary tweeting and perhaps Europe tighting the prices.
If all remained the same, he may have pulled it off.
But things in the wrold change and he didn't have
that vision so time to pass the torch.
Comment by
JAjohnsen on Aug 16, 2016 6:07pm
Realistically, how many of you even see this trending back up to the $30+ range? Obviously assuming MT is replaced with someone more competent.
Comment by
1health on Aug 16, 2016 6:25pm
fdfd12 wrote, Obviously, CEO big mistake was buying a company bigger than they were and thinking the drugs will sell as much as they had in the past for AMCO. What he didn't see happening is price competition, buying off patent drugs, Hillary tweeting and perhaps Europe tighting the prices. HOW COULD NEW CEO CAN CHANGE THESE FACTS.
Comment by
Shortingtozero1 on Aug 16, 2016 7:00pm
This post has been removed in accordance with Community Policy